Document is current
Any future updates will be listed below
-
Authors
George, Sonia
Rey, Nolwen L.
Tyson, Trevor
Esquibel, Corinne
Meyerdirk, Lindsay
Schulz, Emily
Pierce, Steven
Burmeister, Amanda R.
Madaj, Zachary
Steiner, Jennifer A.
Escobar Galvis, Martha L.
Brundin, Lena
Brundin, Patrik
-
Funding
Funding for this research was provided by:
National Institutes of Health (5R21NS093993-02)
- License Information
-
More Information
Article History
Received: 29 October 2018
Accepted: 8 August 2019
First Online: 16 August 2019
Ethics approval
: The housing of the animals and all procedures were in accordance with the Guide for the Care and Use of Laboratory Animals (U.S. National Institutes of Health) and were approved by the Van Andel Research Institute’s IACUC (AUP 16–01-003). This article does not contain any studies with human participants performed by any of the authors.
: P.B. has received commercial support as a consultant from Renovo Neural, Inc., Roche, and Teva Inc., Lundbeck A/S, AbbVie, Neuroderm, Cellular Dynamics International, ClearView Healthcare, FCB Health, IOS Press Partners and Capital Technologies, Inc. P.B. has received commercial support for grants/research from Renovo and Teva/Lundbeck. P.B. has ownership interests in Acousort AB and is on the steering committee of the NILO-PD trial. The authors declare no additional competing financial interests.
